Rubicon Research Ltd
NSE: RUBICON | BSE: 544578
₹1,536.80
₹-38.80
(-2.46%)
As on 08-Oct-2026 12:49IST
Market cap
₹25,734 Cr
Revenue (TTM)
₹1,936 Cr
P/E Ratio
89.3
P/B Ratio
19.2
Div. Yield
0.1 %
Quality Score
2/10
Growth Score
9/10
Valuation Score
1/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹288 Cr
-
ROE
27.8 %
-
ROCE
29.2 %
-
Industry P/E
44.36
-
EV/EBITDA
55.4
-
Debt to Equity
0.2
-
Book Value
₹81.1
-
EPS
₹17.7
-
Face value
1
-
Shares outstanding
165,531,908
10 Years Aggregate
CFO
₹399.72 Cr
EBITDA
₹1,006.26 Cr
Net Profit
₹488.05 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rubicon Research
| 125.8 | -12.1 | 11.4 | -- | -- | -- | -- |
|
BSE Healthcare
| 11.8 | -5.3 | -2.4 | 10.2 | 20.0 | 13.1 | 11.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rubicon Research
|
1,536.8 | 25,733.6 | 1,935.8 | 288.2 | 20.6 | 29.8 | 89.3 | 19.2 |
| 3,064.7 | 25,703.4 | 1,461.8 | 387.4 | 34.5 | 25.2 | 66.6 | 14.9 | |
| 805.6 | 16,084.8 | 7,784.0 | 688.5 | 10.6 | 14 | 23.2 | 2.8 | |
| 443.4 | 17,061.9 | 2,141.5 | 58.5 | 5.8 | 3.3 | 160.6 | 4.4 | |
| 825.3 | 22,740.3 | 5,632.3 | 662.4 | 17.2 | 14.3 | 34.3 | 4.6 | |
| 928.0 | 15,045.7 | 8,608.3 | 351.6 | 8.7 | 5.7 | 42.7 | 2.1 | |
| 800.8 | 15,829.8 | 3,484.6 | 1,013.8 | 24.6 | 12.8 | 13.8 | 1.7 | |
| 1,472.0 | 17,073.8 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 2.9 | |
| 197.2 | 26,686.9 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.3 | |
| 2,047.2 | 33,798.4 | 3,564.0 | 414.0 | 15.3 | 8.4 | 82.6 | 6.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Rubicon Research
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using... a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption. The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant. The company was incorporated in 1999 and is based in Mumbai, India. Read more
-
Incorporated
1999
-
Chairman
Venkat Changavalli
-
Managing Director
Pratibha Pilgaonkar
-
Headquarters
Thane, Maharashtra
-
Website
Looking for more details about Rubicon Research Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Rubicon Research
What is the current share price of Rubicon Research Ltd Today?
The share price of Rubicon Research Ltd is ₹1,536.80 (NSE) and ₹1,533.35 (BSE) as of 08-Oct-2026 12:49 IST. Rubicon Research Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Rubicon Research Ltd?
The P/E ratio of Rubicon Research Ltd is 89.29 times as on 08-Oct-2026, a 101 premium to its peers’ median range of 44.36 times.
The P/B ratio of Rubicon Research Ltd is 19.17 times as on 08-Oct-2026, a 308 premium to its peers’ median range of 4.70 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
51.69 |
10.14 |
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.00 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
What is the 52 Week High and Low of Rubicon Research Ltd?
The 52-week high and low of Rubicon Research Ltd are Rs 1,899.00 and Rs 570.75 as of 08-Oct-2026.
What is the market cap of Rubicon Research Ltd?
Rubicon Research Ltd has a market capitalisation of ₹ 25,734 Cr as on 08-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Rubicon Research Ltd?
Before investing in Rubicon Research Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.